J7503 HCPCS code: Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
J7503 is the HCPCS Level II code for tacrolimus, extended release, (envarsus xr), oral, 0.25 mg. In 2024 Medicare paid an average of $1.35 per service for J7503 across 70,477,400 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3600 per day on DME suppliers. Medicare volume fell 1% from 2022 to 2024 (71,546,089 to 70,477,400 services). In 2024, 2,688 suppliers billed Medicare for J7503 (purchases), serving 15,946 beneficiaries; Illinois, New York, Missouri accounted for 24% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2016-01-01 |
| Last action effective | 2019-01-01 |
Who bills J7503 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 2,688 |
| Referring clinicians | 4,553 |
| Medicare beneficiaries | 15,946 |
| States with claims | 52 |
| Share of services in top 3 states (Illinois, New York, Missouri) | 24% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 2,130 | 14,612 |
| 2023 | 2,402 | 15,469 |
| 2024 | 2,688 | 15,946 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7503, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 71,546,089 | 14,612 | $1.53 | $1.19 |
| 2023 | 71,592,205 | 15,469 | $1.64 | $1.27 |
| 2024 | 70,477,400 | 15,946 | $1.75 | $1.35 |
States with the most J7503 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 6,751,217 | $1.36 |
| New York | 5,478,877 | $1.36 |
| Missouri | 4,720,636 | $1.36 |
| California | 4,611,897 | $1.36 |
| Florida | 4,275,801 | $1.36 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 3600 | Prescribing Information |
| outpatient hospital claims | 120 | Prescribing Information |
What changed for J7503
- 2016-01-01: J7503 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7503?
J7503 is the HCPCS Level II code for tacrolimus, extended release, (envarsus xr), oral, 0.25 mg. Short descriptor: "Tacrol envarsus ex rel oral".
How much does Medicare pay for J7503?
In 2024, the average Medicare payment was $1.35 per service (average allowed $1.75).
Does Medicare cover J7503?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7503 can be billed per day?
3600 on DME suppliers; 120 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7503
- Watch J7503 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7503
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.